Showing 801 - 820 results of 2,756 for search 'materials dysfunction', query time: 0.14s Refine Results
  1. 801

    Heart failure development in patients with arterial hypertension and various variants of heart remodeling by V. R. Veber, M. P. Rubanova, S. V. Zhmaylova, P. M. Gubskaya

    Published 1970-01-01
    “…To study the prognosis of heart failure (HF) development in male and female patients with arterial hypertension (AH) and various heart remodeling variants. Material and methods. The study included 48 men and 41 women of comparable age, with Stage II AH, at baseline free of HF or other diseases resulting in heart remodeling. …”
    Get full text
    Article
  2. 802
  3. 803
  4. 804

    Clinical and functional state of the retina after inadequate laser coagulation of peripheral vitreochorioretinal dystrophies. Part 1. Electroretinography by V. V. Neroev, G. Yu. Zakharova, I. V. Tsapenko, M. V. Zueva, T. D. Okhotsimskaya, B. M. Magamadov

    Published 2020-05-01
    “…Electrophysiological markers of macular dysfunction development risk associated with massive LC of the retina are proposed. …”
    Get full text
    Article
  5. 805
  6. 806
  7. 807

    Tissue myocardial Doppler echocardiography in the assessment of right ventricular function among patients with pulmonary hypertension of various aetiology by Yu. A. Andreeva, M. A. Saidova, T. V. Martynyuk, V. P. Masenko, I. E. Chazova

    Published 2010-04-01
    “…Although at standard EchoCG, there was no clear evidence of diastolic RV dysfunction, TMD revealed diastolic RB dysfunction in all PH patients. …”
    Get full text
    Article
  8. 808

    INFLUENCE OF THE COMBINATION DRUG PRESTANS (PERINDOPRIL A, AMLODIPINE) ON MORPHO-FUNCTIONAL PARAMETERS OF ARTERIAL BED IN ESSENTIAL HYPERTENSION by Yu. A. Danilogorskaya, E. A. Zheleznykh, E. V. Privalova, A. A. Shchendrygina, Yu. N. Belenkov, I. S. Ilgisonis, M. I. Tishman

    Published 2017-12-01
    “…Recently, the problem of endothelial dysfunction is in high interest. It was proved that microcirculatory disorders play main role in development and progression of target organ damage in essential arterial hypertension (EAH). …”
    Get full text
    Article
  9. 809

    The Nb4C3 MXenzyme Attenuates MASH by Scavenging ROS in a Mouse Model by He S, Lv Y, Gao Z, Peng L

    Published 2025-04-01
    “…Keywords: metabolic dysfunction-associated steatohepatitis, Nb4C3, ROS scavenging, macrophage…”
    Get full text
    Article
  10. 810

    Endothelium-mediated vasodilation: associations with cardiometabolic diseases and their risk factors in aging by A. N. Ryabikov, M. S. Troshina, M. N. Ryabikov, Yu. Yu. Palekhina, E. O. Butakov, S. K. Malyutina

    Published 2024-10-01
    “…To evaluate the association of flow-mediated vasodilation (FMD) with cardiometabolic diseases (CMDs) and their risk factors (RF) in old age.Material and methods. The study was conducted in the Russian population cohort of the HAPIEE project (Novosibirsk, 2015-2018). …”
    Get full text
    Article
  11. 811
  12. 812

    Prognostic value of vascular remodeling parameters in the development of adverse cardiovascular events in patients with gastric cancer by Y. Yu. Kirichenko, I. S. Ilgisonis, P. A. Levin, Y. N. Belenkov

    Published 2022-12-01
    “…In this study, for the first time, a comprehensive assessment of the effect of MAC on endothelial dysfunction and vascular stiffness, including, in the long-term follow-up period, was carried out in patients with gastric cancer. …”
    Get full text
    Article
  13. 813

    Participation of the C-terminal propeptide procollagen type I in the formation of cardiofibrosis in patients with myocardial infarction with preserved left ventricular ejection fra... by A. V. Osokina, V. N. Karetnikova, O. M. Polikutina, A. V. Ivanova, T. B. Pecherina, O. V. Gruzdeva, Yu. A. Dyleva, A. N. Kokov, N. K. Brel, O. L. Barbarash

    Published 2021-03-01
    “…To study the dynamics of procollagen type I carboxy-terminal propeptide (PICP) with an assessment of potential associations with cardiac fibrosis (CF) and diastolic dysfunction (DD) of the left ventricle (LV) during the hospitalization and one year after ST segment elevation myocardial infarction (STEMI).Material and methods. …”
    Get full text
    Article
  14. 814

    Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction by A. N. Kaburova, O. M. Drapkina, S. M. Yudin, S. N. Koretsky, V. V. Makarov, M. S. Pokrovskaya, S. A. Kraevoy, B. B. Shoybonov, I. A. Efimova

    Published 2021-07-01
    “…To study the relationship of gut microbiota (GM) with serum myocardial fibrosis markers in patients with heart failure with preserved ejection fraction (HFpEF).Material and methods. The composition of the gut microbiota among 42 patients with HFpEF aged 67,0 [64,0; 71,5] years (men, 57,1%) was assessed by 16S ribosomal ribonucleic acid sequencing. …”
    Get full text
    Article
  15. 815
  16. 816

    Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus by Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis

    Published 2019-07-01
    “…To study some vascular remodeling markers in hypertensive patients depending on the presence of type 2 diabetes mellitus.Material and methods. The study included patients with essential hypertension 1-2 degrees of increase in blood pressure with/without type 2 diabetes (30 and 32 patients respectively). …”
    Get full text
    Article
  17. 817

    Is there the phenotype of chronic heart failure with “intermediate” left ventricular ejection fraction? Additional echocardiographic criteria for left ventricular systolic dysfunct... by V. V. Syvolap, V. A. Lysenko

    Published 2021-06-01
    “….), their use may be helpful in the final identification of systolic dysfunction in CHF patients with LV EF within the “gray area”. …”
    Get full text
    Article
  18. 818
  19. 819
  20. 820